BALCHEM CORP
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURE PAGE
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: February 20, 2026 | BALCHEM CORPORATION |
|---|---|
| By:/s/ Theodore L. Harris | |
| Theodore L. Harris | |
| Chairman, President and Chief Executive Officer |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ Theodore L. Harris
Theodore L. Harris
Chairman, President and Chief Executive Officer
Date: February 20, 2026
/s/ C. Martin Bengtsson
C. Martin Bengtsson
Executive Vice President and Chief Financial Officer
Date: February 20, 2026
/s/ William A. Backus
William A. Backus
Vice President and Chief Accounting Officer
Date: February 20, 2026
/s/ David B. Fischer
David B. Fischer
Director
Date: February 20, 2026
/s/ Kathleen B. Fish
Kathleen B. Fish
Director
Date: February 20, 2026
/s/ Daniel E. Knutson
Daniel E. Knutson
Director
Date: February 20, 2026
/s/ Olivier Rigaud
Olivier Rigaud
Director
Date: February 20, 2026
/s/ Monica Vicente
Monica Vicente
Director
Date: February 20, 2026
/s/ Matthew D. Wineinger
Matthew D. Wineinger
Director
Date: February 20, 2026
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.